The IMID Forum

Professor Nash interviews Dr Roland Grenningloh from the EMD Serono Research and Development Institute, about his paper describing the PK modelling of the novel Bruton’s tyrosine kinase (BTK) inhibitor, evobrutinib, in disease models for RA and lupus.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Tanaka and Professor Calabrese.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Josef Smolen and Professor Wenhui Xie, respectively.

Professor Nash interviews Professor Kevin Winthrop from Oregon Health Sciences University, Portland or USA, about his paper investigating pneumococcal and tetanus vaccine responses in patients with RA receiving baricitinib treatment.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Winthrop K and Professor Wollenhaupt J, respectively

Professor Nash interviews Professor Bernard Combe from the University of Montpellier, France, about a letter investigating the safety of baricitinib treatment in patients with select comorbidities.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Combe B and Dr. Zhang Z, respectively

Professor Nash interviews Professor Tsutomu Takeuchi from Keio University School of Medicine, about the paper looking at safety profile of baricitinib in Japanese patients.

Professor McInnes reviews key abstract from ACR 2018, relating to pain and JAK inhibitors.

Prof McInnes presents the monthly podcast reviewing two papers from Dr. Chengfeng Qiu and Dr. Camean-Castillo, respectively